{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:48:34Z","timestamp":1762004914197},"reference-count":51,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.3892\/or.2017.5670","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T11:10:37Z","timestamp":1495710637000},"page":"253-262","source":"Crossref","is-referenced-by-count":4,"title":["Silencing of type I\u03b3 phosphatidylinositol phosphate kinase suppresses ovarian cancer cell proliferation, migration and invasion"],"prefix":"10.3892","volume":"38","author":[{"given":"Siyu","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junli","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,5,25]]},"reference":[{"key":"key20180107220853_b1-or-38-01-0253","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20180107220853_b2-or-38-01-0253","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107220853_b3-or-38-01-0253","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc2842","article-title":"Phosphoinositide signalling in cancer: Beyond PI3K and PTEN","volume":"10","author":"Bunney","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"key20180107220853_b4-or-38-01-0253","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107220853_b5-or-38-01-0253","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccr.2005.05.014","article-title":"Mutant PIK3CA promotes cell growth and invasion of human cancer cells","volume":"7","author":"Samuels","year":"2005","journal-title":"Cancer Cell"},{"key":"key20180107220853_b6-or-38-01-0253","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1038\/onc.2014.393","article-title":"Targeting type I\u03b3 phosphatidylinositol phosphate kinase inhibits breast cancer metastasis","volume":"34","author":"Chen","year":"2015","journal-title":"Oncogene"},{"key":"key20180107220853_b7-or-38-01-0253","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00018-002-8465-z","article-title":"Phosphoinositides and signal transduction","volume":"59","author":"Toker","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"key20180107220853_b8-or-38-01-0253","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"key20180107220853_b9-or-38-01-0253","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4161\/cam.21192","article-title":"PIP2 signaling, an integrator of cell polarity and vesicle trafficking in directionally migrating cells","volume":"6","author":"Thapa","year":"2012","journal-title":"Cell Adhes Migr"},{"key":"key20180107220853_b10-or-38-01-0253","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.tcb.2006.03.007","article-title":"Movin' on up: The role of PtdIns(4,5)P(2) in cell migration","volume":"16","author":"Ling","year":"2006","journal-title":"Trends Cell Biol"},{"key":"key20180107220853_b11-or-38-01-0253","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/bcr2471","article-title":"Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer","volume":"12","author":"Sun","year":"2010","journal-title":"Breast Cancer Res"},{"key":"key20180107220853_b12-or-38-01-0253","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1158\/0008-5472.CAN-03-3959","article-title":"Activated signal transducer and activator of transcription (STAT) 3: Localization in focal adhesions and function in ovarian cancer cell motility","volume":"64","author":"Silver","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107220853_b13-or-38-01-0253","doi-asserted-by":"crossref","first-page":"e0130685","DOI":"10.1371\/journal.pone.0130685","article-title":"Effects of flavonoids from Potamogeton crispus L on proliferation, migration, and invasion of human ovarian cancer cells","volume":"10","author":"Du","year":"2015","journal-title":"PLoS One"},{"key":"key20180107220853_b14-or-38-01-0253","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2014.01.008","article-title":"MEK1\/2 inhibitors in the treatment of gynecologic malignancies","volume":"133","author":"Miller","year":"2014","journal-title":"Gynecol Oncol"},{"key":"key20180107220853_b15-or-38-01-0253","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Fresno Vara","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"key20180107220853_b16-or-38-01-0253","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1530\/REP-14-0546","article-title":"Ovarian cancer: Involvement of the matrix metalloproteinases","volume":"150","author":"Al-Alem","year":"2015","journal-title":"Reproduction"},{"key":"key20180107220853_b17-or-38-01-0253","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0303-7207(01)00709-2","article-title":"The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma","volume":"187","author":"Davidson","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"key20180107220853_b18-or-38-01-0253","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1172\/JCI3785","article-title":"Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro","volume":"102","author":"Grandis","year":"1998","journal-title":"J Clin Invest"},{"key":"key20180107220853_b19-or-38-01-0253","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/mi.11.1.4","article-title":"STAT3 signaling: Anticancer strategies and challenges","volume":"11","author":"Johnston","year":"2011","journal-title":"Mol Interv"},{"key":"key20180107220853_b20-or-38-01-0253","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: A leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20180107220853_b21-or-38-01-0253","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/onc.2016.197","article-title":"Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: A potential therapeutic target","volume":"36","author":"Saini","year":"2017","journal-title":"Oncogene"},{"key":"key20180107220853_b22-or-38-01-0253","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd4204","article-title":"PI3K and cancer: Lessons, challenges and opportunities","volume":"13","author":"Fruman","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107220853_b23-or-38-01-0253","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ygyno.2016.07.092","article-title":"Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genes","volume":"142","author":"Wang","year":"2016","journal-title":"Gynecol Oncol"},{"key":"key20180107220853_b24-or-38-01-0253","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1158\/1078-0432.CCR-12-2243","article-title":"New strategies in the treatment of ovarian cancer: Current clinical perspectives and future potential","volume":"19","author":"Banerjee","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20180107220853_b25-or-38-01-0253","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1158\/1535-7163.MCT-11-0996","article-title":"The association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer","volume":"11","author":"Carden","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"key20180107220853_b26-or-38-01-0253","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.1145720","article-title":"The genomic landscapes of human breast and colorectal cancers","volume":"318","author":"Wood","year":"2007","journal-title":"Science"},{"key":"key20180107220853_b27-or-38-01-0253","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ng1975","article-title":"High-throughput oncogene mutation profiling in human cancer","volume":"39","author":"Thomas","year":"2007","journal-title":"Nat Genet"},{"key":"key20180107220853_b28-or-38-01-0253","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","year":"2008","journal-title":"Nature"},{"key":"key20180107220853_b29-or-38-01-0253","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"key20180107220853_b30-or-38-01-0253","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers","volume":"304","author":"Samuels","year":"2004","journal-title":"Science"},{"key":"key20180107220853_b31-or-38-01-0253","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nrd1902","article-title":"Exploiting the PI3K\/AKT pathway for cancer drug discovery","volume":"4","author":"Hennessy","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107220853_b32-or-38-01-0253","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07091","article-title":"Essential roles of PI(3)K-p110\u03b2 in cell growth, metabolism and tumorigenesis","volume":"454","author":"Jia","year":"2008","journal-title":"Nature"},{"key":"key20180107220853_b33-or-38-01-0253","doi-asserted-by":"crossref","first-page":"16296","DOI":"10.1073\/pnas.0607899103","article-title":"The p110\u03b1 isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation","volume":"103","author":"Zhao","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107220853_b34-or-38-01-0253","doi-asserted-by":"crossref","first-page":"ra3","DOI":"10.1126\/scisignal.1161577","article-title":"Phosphoinositide 3-kinase p110\u03b2 activity: Key role in metabolism and mammary gland cancer but not development","volume":"1","author":"Ciraolo","year":"2008","journal-title":"Sci Signal"},{"key":"key20180107220853_b35-or-38-01-0253","doi-asserted-by":"crossref","first-page":"8292","DOI":"10.1073\/pnas.0707761105","article-title":"The p110\u03b2 isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110\u03b3","volume":"105","author":"Guillermet-Guibert","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107220853_b36-or-38-01-0253","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nature06892","article-title":"Angiogenesis selectively requires the p110\u03b1 isoform of PI3K to control endothelial cell migration","volume":"453","author":"Graupera","year":"2008","journal-title":"Nature"},{"key":"key20180107220853_b37-or-38-01-0253","doi-asserted-by":"crossref","first-page":"PE1","DOI":"10.1126\/stke.1999.13.pe1","article-title":"Tangled webs: Evidence of cross-talk between c-Raf-1 and Akt","volume":"1999","author":"Jun","year":"1999","journal-title":"Sci STKE"},{"key":"key20180107220853_b38-or-38-01-0253","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc2559","article-title":"Targeting cancer with small molecule kinase inhibitors","volume":"9","author":"Zhang","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20180107220853_b39-or-38-01-0253","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature01147","article-title":"Recruitment and regulation of phosphatidylinositol phosphate kinase type 1 \u03b3 by the FERM domain of talin","volume":"420","author":"Di Paolo","year":"2002","journal-title":"Nature"},{"key":"key20180107220853_b40-or-38-01-0253","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature01082","article-title":"Type I \u03b3 phosphatidylinositol phosphate kinase targets and regulates focal adhesions","volume":"420","author":"Ling","year":"2002","journal-title":"Nature"},{"key":"key20180107220853_b41-or-38-01-0253","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/pmic.200300591","article-title":"Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays","volume":"3","author":"Wulfkuhle","year":"2003","journal-title":"Proteomics"},{"key":"key20180107220853_b42-or-38-01-0253","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ygyno.2011.07.034","article-title":"Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels","volume":"123","author":"Coticchia","year":"2011","journal-title":"Gynecol Oncol"},{"key":"key20180107220853_b43-or-38-01-0253","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","article-title":"Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting","volume":"278","author":"Gialeli","year":"2011","journal-title":"FEBS J"},{"key":"key20180107220853_b44-or-38-01-0253","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1026028303196","article-title":"Regulation of matrix metalloproteinases: An overview","volume":"253","author":"Chakraborti","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"key20180107220853_b45-or-38-01-0253","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/jcp.21548","article-title":"New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells","volume":"217","author":"Delassus","year":"2008","journal-title":"J Cell Physiol"},{"key":"key20180107220853_b46-or-38-01-0253","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","article-title":"Matrix metalloproteinases and tumor metastasis","volume":"25","author":"Deryugina","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107220853_b47-or-38-01-0253","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0092-8674(91)90642-C","article-title":"Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation","volume":"64","author":"Liotta","year":"1991","journal-title":"Cell"},{"key":"key20180107220853_b48-or-38-01-0253","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1055-3207(18)30071-1","article-title":"The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis","volume":"10","author":"Stetler-Stevenson","year":"2001","journal-title":"Surg Oncol Clin N Am"},{"key":"key20180107220853_b49-or-38-01-0253","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s13402-015-0251-7","article-title":"IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3-diindolylmethane in ovarian cancer cells","volume":"39","author":"Zou","year":"2016","journal-title":"Cell Oncol (Dordr)"},{"key":"key20180107220853_b50-or-38-01-0253","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3892\/ijmm.2013.1431","article-title":"Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo","volume":"32","author":"Zhang","year":"2013","journal-title":"Int J Mol Med"},{"key":"key20180107220853_b51-or-38-01-0253","doi-asserted-by":"crossref","first-page":"34707","DOI":"10.1074\/jbc.M113.512848","article-title":"Phosphatidylinositol phosphate 5-kinase I\u03b3i2 in association with Src controls anchorage-independent growth of tumor cells","volume":"288","author":"Thapa","year":"2013","journal-title":"J Biol Chem"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T18:48:54Z","timestamp":1692816534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2017.5670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,25]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3892\/or.2017.5670"],"URL":"https:\/\/doi.org\/10.3892\/or.2017.5670","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}